Table of Contents

May-June 2007; Volume 4,Issue 3

A

  1. ABRAMOVITZ, MARK

    1. Application of Array-based Genomic and Epigenomic Technologies to Unraveling the Heterogeneous Nature of Breast Tumors: On the Road to Individualized Treatment
      MARK ABRAMOVITZ and BRIAN LEYLAND-JONES
      Cancer Genomics & Proteomics May 2007, 4 (3) 135-145;

  2. AURAJO, ROBYN

    1. Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
      RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
      Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;

B

  1. BAUMGARTEN, AXEL J.

    1. Molecular Analysis of Xenograft Models of Human Cancer Cachexia - Possibilities for Therapeutic Intervention
      AXEL J. BAUMGARTEN, HEINZ-HERBERT FIEBIG and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 223-231;

  2. BAUSCH, NIKO

    1. Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
      HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT
      Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;

  3. BRENNAN, DONAL J.

    1. Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
      DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER
      Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;

  4. BROWN, ROBERT

    1. An Exploration into Study Design for Biomarker Identification: Issues and Recommendations
      JACQUELINE A. HALL, ROBERT BROWN and JIM PAUL
      Cancer Genomics & Proteomics May 2007, 4 (3) 111-119;

  5. BURGER, ANGELIKA M.

    1. Editorial
      ANGELIKA M. BURGER and BRIAN LEYLAND-JONES
      Cancer Genomics & Proteomics May 2007, 4 (3) 107;
    2. Cancer Stem Cells and Individualized Therapy
      SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;
    3. Molecular Analysis of Xenograft Models of Human Cancer Cachexia - Possibilities for Therapeutic Intervention
      AXEL J. BAUMGARTEN, HEINZ-HERBERT FIEBIG and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 223-231;

C

  1. CARDOSO, FATIMA

    1. Individualization of Therapy Using Mammaprint®ì: from Development to the MINDACT Trial
      STELLA MOOK, LAURA J. VAN'T VEER, EMIEL J.T. RUTGERS, MARTINE J. PICCART-GEBHART and FATIMA CARDOSO
      Cancer Genomics & Proteomics May 2007, 4 (3) 147-155;

  2. CHUMSRI, SARANYA

    1. Cancer Stem Cells and Individualized Therapy
      SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;

D

  1. DERVAN, PETER A.

    1. Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
      DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER
      Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;

  2. DUFFY, MICHAEL J.

    1. Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
      DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER
      Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;

E

  1. EDELMAN, MARTIN J.

    1. Cancer Stem Cells and Individualized Therapy
      SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;

  2. EDMISTON, KIRSTEN H.

    1. Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
      RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
      Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;

  3. ESPINA, VIRGINIA

    1. Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
      RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
      Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;

F

  1. FIEBIG, HEINZ-HERBERT

    1. Gene Signature-based Prediction of Tumor Response to Cyclophosphamide
      ANDRÉ KORRAT, THOMAS GREINER, MARTINA MAURER, THOMAS METZ and HEINZ-HERBERT FIEBIG
      Cancer Genomics & Proteomics May 2007, 4 (3) 187-195;
    2. Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
      HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT
      Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;
    3. Molecular Analysis of Xenograft Models of Human Cancer Cachexia - Possibilities for Therapeutic Intervention
      AXEL J. BAUMGARTEN, HEINZ-HERBERT FIEBIG and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 223-231;

  2. FINGLETON, BARBARA

    1. Molecular Targets in Metastasis: Lessons from Genomic Approaches
      BARBARA FINGLETON
      Cancer Genomics & Proteomics May 2007, 4 (3) 211-221;

G

  1. GALLAGHER, WILLIAM M.

    1. Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
      DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER
      Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;

  2. GARTENHAUS, RONALD B.

    1. Post-transcriptional Control of the MCT-1-associated Protein DENR/DRP by RNA-binding Protein AUF1
      KRYSTYNA MAZAN-MAMCZARZ and RONALD B. GARTENHAUS
      Cancer Genomics & Proteomics May 2007, 4 (3) 233-239;

  3. GREINER, THOMAS

    1. Gene Signature-based Prediction of Tumor Response to Cyclophosphamide
      ANDRÉ KORRAT, THOMAS GREINER, MARTINA MAURER, THOMAS METZ and HEINZ-HERBERT FIEBIG
      Cancer Genomics & Proteomics May 2007, 4 (3) 187-195;

H

  1. HALL, JACQUELINE A.

    1. An Exploration into Study Design for Biomarker Identification: Issues and Recommendations
      JACQUELINE A. HALL, ROBERT BROWN and JIM PAUL
      Cancer Genomics & Proteomics May 2007, 4 (3) 111-119;

  2. HAMBURGER, ANNE W.

    1. Cancer Stem Cells and Individualized Therapy
      SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;

  3. HOFMANN, MICHAEL

    1. Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
      HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT
      Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;

K

  1. KELLY, CATHERINE

    1. Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
      DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER
      Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;

  2. KHAKPOUR, NAZANIN

    1. Cancer Stem Cells and Individualized Therapy
      SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;

  3. KORRAT, ANDRE

    1. Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
      HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT
      Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;

  4. KORRAT, ANDRÉ

    1. Gene Signature-based Prediction of Tumor Response to Cyclophosphamide
      ANDRÉ KORRAT, THOMAS GREINER, MARTINA MAURER, THOMAS METZ and HEINZ-HERBERT FIEBIG
      Cancer Genomics & Proteomics May 2007, 4 (3) 187-195;

L

  1. LEYLAND-JONES, BRIAN

    1. Editorial
      ANGELIKA M. BURGER and BRIAN LEYLAND-JONES
      Cancer Genomics & Proteomics May 2007, 4 (3) 107;
    2. Application of Array-based Genomic and Epigenomic Technologies to Unraveling the Heterogeneous Nature of Breast Tumors: On the Road to Individualized Treatment
      MARK ABRAMOVITZ and BRIAN LEYLAND-JONES
      Cancer Genomics & Proteomics May 2007, 4 (3) 135-145;

  2. LIOTTA, LANCE A.

    1. Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
      RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
      Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;

M

  1. MAURER, MARTINA

    1. Gene Signature-based Prediction of Tumor Response to Cyclophosphamide
      ANDRÉ KORRAT, THOMAS GREINER, MARTINA MAURER, THOMAS METZ and HEINZ-HERBERT FIEBIG
      Cancer Genomics & Proteomics May 2007, 4 (3) 187-195;

  2. MAZAN-MAMCZARZ, KRYSTYNA

    1. Post-transcriptional Control of the MCT-1-associated Protein DENR/DRP by RNA-binding Protein AUF1
      KRYSTYNA MAZAN-MAMCZARZ and RONALD B. GARTENHAUS
      Cancer Genomics & Proteomics May 2007, 4 (3) 233-239;

  3. METZ, THOMAS

    1. Gene Signature-based Prediction of Tumor Response to Cyclophosphamide
      ANDRÉ KORRAT, THOMAS GREINER, MARTINA MAURER, THOMAS METZ and HEINZ-HERBERT FIEBIG
      Cancer Genomics & Proteomics May 2007, 4 (3) 187-195;
    2. Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
      HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT
      Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;

  4. MOOK, STELLA

    1. Individualization of Therapy Using Mammaprint®ì: from Development to the MINDACT Trial
      STELLA MOOK, LAURA J. VAN'T VEER, EMIEL J.T. RUTGERS, MARTINE J. PICCART-GEBHART and FATIMA CARDOSO
      Cancer Genomics & Proteomics May 2007, 4 (3) 147-155;

N

  1. NAKANISHI, TAKEO

    1. Drug Transporters as Targets for Cancer Chemotherapy
      TAKEO NAKANISHI
      Cancer Genomics & Proteomics May 2007, 4 (3) 241-254;

P

  1. PAUL, JIM

    1. An Exploration into Study Design for Biomarker Identification: Issues and Recommendations
      JACQUELINE A. HALL, ROBERT BROWN and JIM PAUL
      Cancer Genomics & Proteomics May 2007, 4 (3) 111-119;

  2. PETRICOIN, EMANUEL F.

    1. Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
      RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
      Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;

  3. PHATAK, PORNIMA

    1. Cancer Stem Cells and Individualized Therapy
      SARANYA CHUMSRI, PORNIMA PHATAK, MARTIN J. EDELMAN, NAZANIN KHAKPOUR, ANNE W. HAMBURGER and ANGELIKA M. BURGER
      Cancer Genomics & Proteomics May 2007, 4 (3) 165-174;

  4. PHILLIPS, ROGER M.

    1. Tailoring Targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C
      MILÈNE VOLPATO and ROGER M. PHILLIPS
      Cancer Genomics & Proteomics May 2007, 4 (3) 175-186;

  5. PICCART-GEBHART, MARTINE J.

    1. Individualization of Therapy Using Mammaprint®ì: from Development to the MINDACT Trial
      STELLA MOOK, LAURA J. VAN'T VEER, EMIEL J.T. RUTGERS, MARTINE J. PICCART-GEBHART and FATIMA CARDOSO
      Cancer Genomics & Proteomics May 2007, 4 (3) 147-155;

R

  1. REXHEPAJ, ELTON

    1. Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer
      DONAL J. BRENNAN, CATHERINE KELLY, ELTON REXHEPAJ, PETER A. DERVAN, MICHAEL J. DUFFY and WILLIAM M. GALLAGHER
      Cancer Genomics & Proteomics May 2007, 4 (3) 121-134;

  2. RUTGERS, EMIEL J.T.

    1. Individualization of Therapy Using Mammaprint®ì: from Development to the MINDACT Trial
      STELLA MOOK, LAURA J. VAN'T VEER, EMIEL J.T. RUTGERS, MARTINE J. PICCART-GEBHART and FATIMA CARDOSO
      Cancer Genomics & Proteomics May 2007, 4 (3) 147-155;

S

  1. SCHÜLER, JULIA

    1. Gene Signatures Developed from Patient Tumor Explants Grown in Nude Mice to Predict Tumor Response to 11 Cytotoxic Drugs
      HEINZ-HERBERT FIEBIG, JULIA SCHÜLER, NIKO BAUSCH, MICHAEL HOFMANN, THOMAS METZ and ANDRE KORRAT
      Cancer Genomics & Proteomics May 2007, 4 (3) 197-209;

  2. SPEER, RUNA

    1. Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
      RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
      Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;

V

  1. VEER, LAURA J. VAN'T

    1. Individualization of Therapy Using Mammaprint®ì: from Development to the MINDACT Trial
      STELLA MOOK, LAURA J. VAN'T VEER, EMIEL J.T. RUTGERS, MARTINE J. PICCART-GEBHART and FATIMA CARDOSO
      Cancer Genomics & Proteomics May 2007, 4 (3) 147-155;

  2. VOLPATO, MILÈNE

    1. Tailoring Targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C
      MILÈNE VOLPATO and ROGER M. PHILLIPS
      Cancer Genomics & Proteomics May 2007, 4 (3) 175-186;

W

  1. WULFKUHLE, JULIA

    1. Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy
      RUNA SPEER, JULIA WULFKUHLE, VIRGINIA ESPINA, ROBYN AURAJO, KIRSTEN H. EDMISTON, LANCE A. LIOTTA and EMANUEL F. PETRICOIN
      Cancer Genomics & Proteomics May 2007, 4 (3) 157-164;
Back to top

In this issue